GSK

GSK plc (GSK)

Healthcare • Drug Manufacturers - General

StockLSEUnited KingdomGB00BN7SWP63

19.14 GBP +0.68% today Updated 13 Nov 2026 10:24

Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by GSK plc, and has no access to any account you may have with it. The name and the logo belong to their owners.

Price history

Daily prices in GBP. Dividends, results and news are marked on the day they happened; click a day to see them.

All time

Updated 13 Nov 2026 10:24. Information, not advice. Showing the last 12 months. Create a free account to see the whole history

Results

Next results 03 Feb 2027 in 82 days · 11:00 · estimate 0.28

Last results 0.55 vs 0.51 estimated 27 Oct 2026 · Beat +7.3%

Beat the estimate 11 of 12 1 missed · 0 in line · 11 beats in a row

Average surprise +11.2% reported against the estimate, last 12 quarters

Earnings per share: estimate and reported

Estimate Reported: beat Reported: miss In line

Quarterly results

Date	EPS estimate	EPS reported	Surprise	Result
03 Feb 2027 11:00	0.28	—	—	Upcoming
27 Oct 2026 20:00	0.51	0.55	+7.3%	Beat
28 Jul 2026 07:00	0.47	0.51	+8.0%	Beat
29 Apr 2026 02:00	0.44	0.47	+4.9%	Beat
04 Feb 2026 02:00	0.23	0.26	+11.2%	Beat
29 Oct 2025 03:00	0.47	0.55	+16.8%	Beat
30 Jul 2025 02:00	0.42	0.47	+10.1%	Beat
30 Apr 2025 02:00	0.40	0.45	+12.2%	Beat
05 Feb 2025 02:00	0.19	0.23	+22.9%	Beat
30 Oct 2024 03:00	0.43	0.50	+16.0%	Beat
31 Jul 2024 02:00	0.39	0.43	+12.4%	Beat
01 May 2024 02:00	0.37	0.43	+17.0%	Beat
31 Jan 2024 02:00	0.30	0.29	-4.0%	Miss
01 Nov 2023 03:00	0.46	0.50	+9.1%	Beat
26 Jul 2023 02:00	0.34	0.39	+13.0%	Beat
26 Apr 2023 02:00	0.33	0.37	+10.6%	Beat
01 Feb 2023 02:00	0.22	0.26	+17.6%	Beat
02 Nov 2022 03:00	0.39	0.47	+19.0%	Beat
27 Jul 2022 02:00	0.30	0.35	+16.3%	Beat
27 Apr 2022 02:00	0.37	0.41	+9.5%	Beat
09 Feb 2022 02:00	0.29	0.32	+8.7%	Beat
27 Oct 2021 07:00	0.37	0.46	+25.1%	Beat
28 Jul 2021 07:00	0.25	0.35	+40.8%	Beat
28 Apr 2021 07:00	0.26	0.29	+8.2%	Beat
03 Feb 2021 07:00	0.29	0.29	+1.2%	Beat
28 Oct 2020 08:00	0.38	0.45	+17.9%	Beat
29 Jul 2020 07:00	0.25	0.24	-3.6%	Miss
29 Apr 2020 07:00	0.39	0.47	+19.8%	Beat
05 Feb 2020 07:00	0.32	0.31	-2.8%	Miss
30 Oct 2019 08:00	0.41	0.48	+17.0%	Beat
24 Jul 2019 07:00	0.32	0.38	+20.0%	Beat
01 May 2019 07:00	0.32	0.38	+16.2%	Beat
06 Feb 2019 07:00	0.35	0.39	+11.6%	Beat
31 Oct 2018 08:00	0.42	0.44	+6.5%	Beat
25 Jul 2018 06:00	0.32	0.35	+9.8%	Beat
25 Apr 2018 07:00	0.30	0.31	+1.1%	Beat
07 Feb 2018 07:00	0.33	0.34	+4.6%	Beat
25 Oct 2017 07:00	0.40	0.41	+1.5%	Beat
26 Jul 2017 06:00	0.33	0.34	+4.3%	Beat
26 Apr 2017 07:00	0.31	0.31	+2.2%	Beat
08 Feb 2017 07:00	0.31	0.33	+4.5%	Beat
26 Oct 2016 07:00	0.37	0.40	+9.2%	Beat
27 Jul 2016 07:00	0.26	0.31	+18.1%	Beat
27 Apr 2016 06:00	0.22	0.25	+10.2%	Beat
03 Feb 2016 07:00	0.22	0.22	-0.8%	In line
28 Oct 2015 08:00	0.24	0.29	+18.6%	Beat
29 Jul 2015 07:00	0.21	0.22	+2.0%	Beat
06 May 2015 07:00	0.22	0.22	-1.5%	Miss
04 Feb 2015 07:00	0.33	0.34	+3.9%	Beat
22 Oct 2014 07:00	0.30	0.35	+16.3%	Beat

Annual results · GBP

Year	Revenue	Change	Net income	Net margin	EPS	EPS change	Free cash flow
2025	32.7B	+4.1%	5.7B	17.5%	1.39	+123.2%	4.8B
2024	31.4B	+3.5%	2.6B	8.2%	0.62	-48.1%	3.6B
2023	30.3B	+3.4%	4.9B	16.2%	1.20	-67.3%	4.4B
2022	29.3B	—	15B	51.0%	3.66	—	5.1B

Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.

Prices by day, week and month

Day Week Month

Price history in GBP, by day
Period	Opening price	High	Low	Closing price	Change	Volume	Dividend
13 Nov 2026	18.98	19.19	18.96	19.14	+0.68%	319,689
12 Nov 2026	19.10	19.19	18.89	19.01	+0.74%	4,345,406	0.1700
11 Nov 2026	19.17	19.20	18.76	18.87	-1.56%	3,834,472
10 Nov 2026	19.24	19.45	19.16	19.17	+0.66%	4,847,703
09 Nov 2026	18.85	19.16	18.85	19.05	+0.77%	4,197,241
06 Nov 2026	18.71	18.90	18.28	18.90	0.00%	6,698,923
05 Nov 2026	19.05	19.16	18.76	18.90	0.00%	5,325,114
04 Nov 2026	18.16	18.96	18.02	18.90	+3.42%	10,739,101
03 Nov 2026	18.35	18.48	18.27	18.28	+0.16%	5,019,742
02 Nov 2026	18.32	18.46	18.24	18.25	-1.64%	5,439,807
00 Mon 0000	157.29	236.48	315.67	394.86	+0.00%	000,000
00 Mon 0000	553.24	632.43	711.62	790.81	+0.00%	000,000
00 Mon 0000	49.19	128.38	207.57	286.76	+0.00%	000,000
1,260 older periods: create a free account to see the whole history

Prices in GBP, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.

News

GSK (LSE:GSK) Settles Key Vaccine Patent Case And Wins Broad Europe Injunction (opens in a new tab) Simply Wall St. · 13 Nov 2026 01:18
Is GSK (LSE:GSK) A Bargain Following Its New Alamar Collaboration? (opens in a new tab) Simply Wall St. · 13 Nov 2026 00:18
What GSK (LSE:GSK)'s Cancer And HIV Trial Wins Mean For Shareholders (opens in a new tab) Simply Wall St. · 09 Nov 2026 21:08
Why Is GSK (LSE:GSK) Drawing Attention For New Cancer Data And Proteomics? (opens in a new tab) Simply Wall St. · 09 Nov 2026 19:15
GSK Accelerates Late-Stage Studies as It Targets COPD and Long-Acting Respiratory Treatments (opens in a new tab) MarketBeat · 09 Nov 2026 19:15
GSK (LSE:GSK) Stock Still Looks Below Fair Value Following Jemperli Approval (opens in a new tab) Simply Wall St. · 06 Nov 2026 10:18
HP Names Emma Walmsley as New CEO, Ending Monthlong Search (opens in a new tab) Bloomberg · 04 Nov 2026 12:44
GSK (LSE:GSK) Wins FDA Nod For Jemperli As ESMO Data Builds Oncology Case (opens in a new tab) Simply Wall St. · 01 Nov 2026 11:15
GSK vs. Moderna: Which Large-Cap Biotech Stock Offers More Growth? (opens in a new tab) Zacks · 29 Oct 2026 15:23
GSK (LSE:GSK) Shares Dropped, So What Is Behind The Latest Attention? (opens in a new tab) Simply Wall St. · 29 Oct 2026 08:23
Glaxo: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 28 Oct 2026 18:36
What GSK (GSK) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 28 Oct 2026 18:04
GSK Fumbles On Vaccines, HIV — Reversing An 11% Pre-Earnings Run (opens in a new tab) Investor's Business Daily · 28 Oct 2026 15:58
GSK Q3 Earnings Top Mark, Stock Down on Soft Vaccines Sales (opens in a new tab) Zacks · 28 Oct 2026 14:45
What GSK Needs to Do After Weak Vaccine Sales Spoil an Earnings Beat (opens in a new tab) Barrons.com · 28 Oct 2026 14:15

Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.

Key data

Previous close: 19.01 GBP
Market cap: 76.2B
Dividend yield: 0.04%
5-year average yield: 4.09%
Payout ratio: 64%
Last dividend: 0.0017 GBP · 12 Nov 2026
Next ex-dividend date: 12 Nov 2026
Exchange: LSE
Country: United Kingdom
Sector: Healthcare
Industry: Drug Manufacturers - General
Currency: GBP

Dividends

Ex-dividend date	Per share
12 Nov 2026	0.1700 GBP
13 Aug 2026	0.1700 GBP
14 May 2026	0.1700 GBP
19 Feb 2026	0.1800 GBP
00 Mon 0000	394.8600 GBP
00 Mon 0000	474.0500 GBP
8 older dividends: create a free account to see them

Why this score

How the score is made up
Part of the score	Points	Why
Yield Dividends per year as a share of today's price. Very high yields count for less: they often signal trouble.	0.2 / 25	Yield of 0.0% on today's price
Dividend safety Can the company keep paying? The dividend against free cash flow and earnings, plus debt and interest cover.	8.8 / 25	Dividend uses 57% of free cash flow (3-year average)
Dividend growth How many years in a row the dividend has risen, and how fast.	1.5 / 15	Dividend up 2 years in a row, -3.7% a year
Quality Return on equity, net margin and how stable the margins are.	9.2 / 15	ROE of 28%
Valuation Free cash flow yield and the P/E against its sector.	10.0 / 10	P/E 17.8 against 30.6 for its sector
Analysts How far the analysts' average target is from today's price.	3.7 / 5	Analysts' target is +12% from the price

Score capped at 50: the dividend was cut recently
The dividend paid in the last 12 months is lower than in the 12 before

Income profile: it pays a dividend, so it is scored mainly on the dividend and how safe it is. Based on 95% of the figures (grade A). Warnings take 6 points off.

Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works

Figures

Valuation
Figure	Value	Reading	Sector median
P/E (trailing)	17.77×	Fair	30.56×
P/E (forward)	10.13×	Good	14.16×
Price / book	4.06×	Weak	3.5×
Price / sales	2.27×	Fair	3.33×
EV / EBITDA	8.41×	Good	11.19×
Free cash flow yield	7.3%	Good	2.1%

Quality
Figure	Value	Reading	Sector median
Gross margin	73.8%	Good	54.9%
Operating margin	30.5%	Good	5.8%
Net margin	13%	Good	1.2%
Return on equity	28.3%	Good	4.4%
Return on assets	9.6%	Good	2.7%

Growth
Figure	Value	Reading	Sector median
Revenue growth / year	3.7%	Fair	10.1%
EPS growth / year	-27.6%	Weak	10.2%

Financial health
Figure	Value	Reading	Sector median
Debt / equity	1.3×	Fair	0.4×
Net debt / EBITDA	1.81×	Fair	1.46×
Interest cover	12.14×	Good	2.17×
Current ratio	0.86×	Weak	2.64×

Dividends
Figure	Value	Reading	Sector median
Payout of earnings	63.6%	Fair	0%
Payout of free cash flow	46.2%	Good	28.7%
Payout of free cash flow (3 years)	56.9%	Fair	—
Dividend growth / year	-3.7%	Weak	6.5%
Years of rising dividends	2	Weak	1.5

The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.

Similar shares

Follow GSK and get alerts

Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.

Start for free Log in